Alexium International Group Limited ASX: AJX, NASDAQ Designation: AXXIY is pleased to announce the successful completion of a placement (Placement) of 34.3 million new Alexium shares (New Shares). The New Shares will be issued at a price of $0.35 per New Share, which represents a 7.9% discount to the last close price of $0.38 on Wednesday 6 December 2017 and a 5.2% discount to the 30 day volume weighted price.
The placement was oversubscribed and the Board of Alexium welcomes a number of new institutional investors to the register and thanks existing institutions for their ongoing support. Members of the Board and Management of the Company have committed to subscribing for approximately 750,000 New Shares, being $275,000 subject to shareholder approval, to be sought at a general meeting of the Company to be held at the earliest convenient time. These shares are included in the 34,300,000 to be issued pursuant to this equity raising. A notice of meeting will be issued shortly.
The institutional investor placement shares are expected to be issued on 15 December 2017; 4,000,000 shares will be issued under Listing Rule 7.1 and 30,300,000 under Listing Rule 7.1A. The Board and Management shares will be issued after the general meeting, subject to Shareholder approval.
Petra Capital acted as Sole Lead Manager and Bookrunner to the equity raising.
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.